Abstract
Purpose
The purpose of the present study was to investigate the incidence and associated factors for early death in stage IV colorectal cancer (CRC) and to construct the predictive nomogram.
Methods
Patients with stage IV CRC, who had been diagnosed between 2010 and 2014 in the Surveillance, Epidemiology, and End Results datasets, were eligible for this retrospective cohort study. The univariable and multivariable logistic regression models were conducted to determine the associated factors for early death (survival time ≤ 3 months). The predictive nomogram was constructed and the internal validation was performed.
Results
Ten thousand two hundred sixty-three out of 36,461 (28.1%) eligible patients resulted in all causes of early death (25.8% for cancer-specific early death and 2.3% for non-cancer early death). Advanced age, marital status, right colon, poor differentiation, higher N stage, and bone metastasis were positively associated with all causes of early death, cancer-specific early death, and non-cancer early death, while higher T stage, positive carcinoembryonic antigen, and distant metastases (bone, lung, liver, and brain) were only positively associated with all causes of early death and cancer-specific early death. The calibration curve for all causes of early death, cancer-specific early death, and non-cancer early death showed the prediction curve closely approximated at the 45° line and the areas under the curve were 75.7% (95% CI, 74.9–76.4%), 75.9% (95% CI, 75.1–76.6%), and 76.9% (95% CI, 76.3–77.6%), respectively.
Conclusions
The nomogram was calibrated to predict all causes of early death development, cancer-specific early death development, and non-cancer early death development. These findings can be utilized in early screening and to tailor targeted treatment regimens for stage IV CRC patients.
Similar content being viewed by others
References
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386
Van Cutsem E, Oliveira J (2009) Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl):461–463
Lee YC, Lee YL, Chuang JP, Lee JC (2013) Differences in survival between colon and rectal cancer from SEER data. PLoS One 8(11):e78709
Kawamura H, Yamaguchi T, Yano Y, Hozumi T, Takaki Y, Matsumoto H, Nakano D, Takahashi K (2018) Characteristics and prognostic factors of bone metastasis in patients with colorectal cancer. Dis Colon Rectum 61(6):673–678
Rutter CM, Johnson EA, Feuer EJ, Knudsen AB, Kuntz KM, Schrag D (2013) Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst 105(23):1806–1813
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6): 1471–1474
Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383(9927):1490–1502
Del CHL, Virgili MA, Szafranska J, Martin-Richard M, Paez LD, Sebio GA et al (2018) Brain metastases in colorectal cancer: prognostic factors and survival analysis. Int J Color Dis 33(11):1517–1523
Jochems A, El-Naqa I, Kessler M, Mayo CS, Jolly S, Matuszak M et al (2018) A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy. Acta Oncol 57(2):226–230
Inoue T, Tamiya M, Tamiya A, Nakahama K, Taniguchi Y, Shiroyama T, Isa SI, Nishino K, Kumagai T, Kunimasa K, Kimura M, Suzuki H, Hirashima T, Atagi S, Imamura F (2018) Analysis of early death in Japanese patients with advanced non-small-cell lung cancer treated with nivolumab. Clin Lung Cancer 19(2):e171–e176
Luo D, Liu Q, Yu W, Ma Y, Zhu J, Lian P, Cai S, Li Q, Li X (2018) Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study. Int J Color Dis [Epub ahead of print], 33, 1241, 1249
Kruser TJ, Chao ST, Elson P, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Pelley R, Suh JH (2008) Multidisciplinary management of colorectal brain metastases: a retrospective study. Cancer 113(1):158–165
Shervani S, Lu G, Sager K, Wajima T, Wong L (2018) Prognostic factors and hazard ratios in colorectal cancer patients over 80 years of age: a retrospective, 20-year, single institution review. J Gastrointest Oncol 9(2):254–262
Baghestani AR, Daneshvar T, Pourhoseingholi MA, Asadzade H (2014) Survival of colorectal cancer patients in the presence of competing-risk. Asian Pac J Cancer Prev 15(15):6253–6255
Lionti S, Reggiani BL, Bettelli S, Spallanzani A, Gelsomino F, Barresi V (2018) Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters. Hum Pathol:78115–78124
Wang R, Wang MJ, Ping J (2015) Clinicopathological features and survival outcomes of colorectal cancer in young versus elderly: a population-based cohort study of SEER 9 registries data (1988-2011). Medicine (Baltimore) 94(35):e1402
O’Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY (2004) Do young colon cancer patients have worse outcomes? World J Surg 28(6):558–562
Troncone E, Marafini I, Stolfi C, Monteleone G (2018) Transforming growth factor-beta1/Smad7 in intestinal immunity, inflammation, and cancer. Front Immunol 91407:9
Janakiram NB, Rao CV (2014) The role of inflammation in colon cancer. Adv Exp Med Biol:81625–81652
O’Connell JB, Maggard MA, Livingston EH, Yo CK (2004) Colorectal cancer in the young. Am J Surg 187(3):343–348
Wang Y, Yang L, Zhou M, Shen L, Zhang J, Deng W et al (2018) Disparities in survival for right-sided vs. left-sided colon cancers in young patients: a study based on the Surveillance, Epidemiology, and End Results database (1990-2014). Cancer Manag Res:101735–101747
Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N (2008) Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 15(9):2388–2394
Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H (2010) Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 53(1):57–64
Petrelli F, Tomasello G, Borgonovo K, Ghidini M, Turati L, Dallera P, et al. (2016) Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol
Yahagi M, Okabayashi K, Hasegawa H, Tsuruta M, Kitagawa Y (2016) The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis. J Gastrointest Surg 20(3):648–655
Arnold D, Lueza B, Douillard JY, Peeters M, Lenz HJ, Venook A, Heinemann V, van Cutsem E, Pignon JP, Tabernero J, Cervantes A, Ciardiello F (2017) Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann Oncol 28(8):1713–1729
Guan NC, Termorshuizen F, Laan W, Smeets HM, Zainal NZ, Kahn RS, de Wit NJ, Boks MPM (2013) Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer. Soc Psychiatry Psychiatr Epidemiol 48(8):1289–1295
Mazzotti F, Cucchetti A, Claassen Y, Bos A, Bastiaannet E, Ercolani G, et al. (2019) Years of life lost for older patients after colorectal cancer diagnosis. World J Surg
Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD (2003) Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196(5):722–728
Vennix S, Pelzers L, Bouvy N, Beets GL, Pierie JP, Wiggers T, et al. (2014) Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev (4): D5200
Huang L, Li TJ, Zhang JW, Liu S, Fu BS, Liu W (2014) Neoadjuvant chemotherapy followed by surgery versus surgery alone for colorectal cancer: meta-analysis of randomized controlled trials. Medicine (Baltimore) 93(28):e231
Funding
Natural Science Foundation of China (81702161, 81801781, and 81802508); Natural Science Foundation of the Tianjin Science and Technology Committee of China (17JCQNJC11000); Natural Science Foundation of Tianjin Medical University (2016KYZQ10); Doctor Start-up Grant of Tianjin Medical University Cancer Institute and Hospital (B1711); Top talent training program of the first affiliated hospital of PLA Army Medical University (SWH2018BJKJ-12).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The present study was complied with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, X., Mao, M., Xu, G. et al. The incidence, associated factors, and predictive nomogram for early death in stage IV colorectal cancer. Int J Colorectal Dis 34, 1189–1201 (2019). https://doi.org/10.1007/s00384-019-03306-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-019-03306-1